Health
HPV vaccines for adults over age 26 may not be cost-effective – HSPH News
For immediate release: Thursday, March 11, 2021 Boston, MA – Vaccinating adults age 26 and older against the human papillomavirus (HPV)—the virus that causes more…
For immediate release: Thursday, March 11, 2021
Boston, MA Vaccinating adults age 26 and older against the human papillomavirus (HPV)the virus that causes more than 90% of cervicalcancers as well as several other cancersmay not be cost-effective, according to a new study led by researchers at the Harvard T.H. School of Public Health.
Our study found that the added health benefit of increasing the vaccination age limit beyond 26 years is minimal, and that the cost-effectiveness is much lower than…
-
Business13 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General21 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business15 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
General13 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips